keyword
https://read.qxmd.com/read/30001930/cognitive-behavioural-therapy-in-clozapine-resistant-schizophrenia-focus-an-assessor-blinded-randomised-controlled-trial
#21
RANDOMIZED CONTROLLED TRIAL
Anthony P Morrison, Melissa Pyle, Andrew Gumley, Matthias Schwannauer, Douglas Turkington, Graeme MacLennan, John Norrie, Jemma Hudson, Samantha E Bowe, Paul French, Rory Byrne, Suzy Syrett, Robert Dudley, Hamish J McLeod, Helen Griffiths, Thomas R E Barnes, Linda Davies, David Kingdon
BACKGROUND: Although clozapine is the treatment of choice for treatment-refractory schizophrenia, 30-40% of patients have an insufficient response, and others are unable to tolerate it. Evidence for any augmentation strategies is scarce. We aimed to determine whether cognitive behavioural therapy (CBT) is an effective treatment for clozapine-resistant schizophrenia. METHODS: We did a pragmatic, parallel group, assessor-blinded, randomised controlled trial in community-based and inpatient mental health services in five sites in the UK...
August 2018: Lancet Psychiatry
https://read.qxmd.com/read/29880569/multinational-comparative-cross-sectional-survey-of-views-of-medical-students-about-acceptable-terminology-and-subgroups-in-schizophrenia
#22
JOURNAL ARTICLE
Shanaya Rathod, Muhammad Irfan, Rachna Bhargava, Narsimha Pinninti, Joseph Scott, Haifa Mohammad Algahtani, Zhihua Guo, Rishab Gupta, Pallavi Nadkarni, Farooq Naeem, Fleur Howells, Katherine Sorsdahi, Kerensa Thorne, Victoria Osman-Hicks, Sasee Pallikadavath, Peter Phiri, Hannah Carr, Lizi Graves, David Kingdon
AIM: The aim of this study was to inform thinking around the terminology for 'schizophrenia' in different countries. OBJECTIVES: The objective of this study was to investigate: (1) whether medical students view alternative terminology (psychosis subgroups), derived from vulnerability-stress models of schizophrenia, as acceptable and less stigmatising than the term schizophrenia; (2) if there are differences in attitudes to the different terminology across countries with different cultures and (3) whether clinical training has an impact in reducing stigma...
June 7, 2018: BMJ Open
https://read.qxmd.com/read/29414118/the-structured-ambivalence-of-cannabis-control-in-england-wales
#23
JOURNAL ARTICLE
David Brewster
The two reclassifications of cannabis in England & Wales in 2004 and 2009 have been subjected to a series of academic analyses which have largely been centred on either the relationship to evidence, or in terms of the implications and realities of policing and health under the changes. However, despite the wealth of attention on this area, there have been relatively few attempts to understand these policy movements through broader criminological theoretical frameworks. One recent exception is Shiner's (2015) utilisation of Garland's (2001) concept of 'structured ambivalence'...
March 2018: International Journal on Drug Policy
https://read.qxmd.com/read/29129504/cognitive-therapy-of-psychosis-research-and-implementation
#24
REVIEW
David Kingdon, Douglas Turkington
No abstract text is available yet for this article.
January 2019: Schizophrenia Research
https://read.qxmd.com/read/29126262/relapsing-polychondritis-a-clinical-review-for-rheumatologists
#25
REVIEW
Jack Kingdon, Joseph Roscamp, Shirish Sangle, David D'Cruz
Relapsing polychondritis (RPC) is a rare autoimmune rheumatic disorder that is traditionally classified as a systemic vasculitis. It is characterized by inflammation of cartilage, and typical presenting features include chondritis of the nasal bridge, auricular chondritis, ocular inflammation and involvement of the bronchial tree. Its rarity often leads to considerable delay in establishing a diagnosis and poses a significant management challenge to clinicians, as no conventional guidelines exist. This review summarizes the clinical features of RPC and provides guidance for rheumatologists on making the diagnosis and assessing organ involvement...
September 1, 2018: Rheumatology
https://read.qxmd.com/read/28812313/current-and-potential-pharmacological-and-psychosocial-interventions-for-anxiety-symptoms-and-disorders-in-patients-with-schizophrenia-structured-review
#26
REVIEW
Fleur M Howells, David G Kingdon, David S Baldwin
OBJECTIVE: Between 30% and 62% of patients with schizophrenia present with co-morbid anxiety disorders that are associated with increased overall burden. Our aim was to summarize current and potential interventions for anxiety in schizophrenia. DESIGN: Structured review, summarizing pharmacological and psychosocial interventions used to reduce anxiety in schizophrenia and psychosis. RESULTS: Antipsychotics have been shown to reduce anxiety, increase anxiety, or have no effect...
September 2017: Human Psychopharmacology
https://read.qxmd.com/read/28584656/improving-the-quality-of-mental-health-services-using-patient-outcome-data-making-the-most-of-honos
#27
REVIEW
Mike J Crawford, Mo Zoha, Alastair J D Macdonald, David Kingdon
Efforts to assess and improve the quality of mental health services are often hampered by a lack of information on patient outcomes. Most mental health services in England have been routinely collecting Health of the Nation Outcome Scales (HoNOS) data for some time. In this article we illustrate how clinical teams have used HoNOS data to identify areas where performance could be improved. HoNOS data have the potential to give clinical teams the information they need to assess the quality of care they deliver, as well as develop and test initiatives aimed at improving the services they provide...
June 2017: BJPsych Bulletin
https://read.qxmd.com/read/28390407/a-qualitative-study-to-explore-views-of-patients-carers-and-mental-health-professionals-to-inform-cultural-adaptation-of-cbt-for-psychosis-cbtp-in-china
#28
JOURNAL ARTICLE
Weihui Li, Li Zhang, Xuerong Luo, Bangshan Liu, Zhipeng Liu, Fang Lin, Zhiling Liu, Yuhuan Xie, Melissa Hudson, Shanaya Rathod, David Kingdon, Nusrat Husain, Xudong Liu, Muhammad Ayub, Farooq Naeem
BACKGROUND: The evidence for effectiveness of Cognitive Behaviour Therapy (CBT) is robust and the national organizations in the United Kingdom and the United States recommend its use. It is not utilized to its full potential in low and middle-income countries. Adaptation of CBT treatment to the target culture may facilitate its uptake. This study explored views of patients with schizophrenia, their caregivers, and mental health professionals for the purpose of cultural adaptation of CBT...
April 8, 2017: BMC Psychiatry
https://read.qxmd.com/read/28069563/brief-cognitive-behavioural-therapy-for-patients-in-the-community-with-schizophrenia-randomised-controlled-trial-in-beijing-china
#29
RANDOMIZED CONTROLLED TRIAL
Zhi-Hua Guo, Zhan-Jiang Li, Yun Ma, Jing Sun, Jun-Hua Guo, Wen-Xiu Li, Zhi-Qiang Wang, Hui-Li Xu, Roger M K Ng, Douglas Turkington, David Kingdon
Background Brief cognitive-behavioural therapy (CBT) is an emerging treatment for schizophrenia in community settings; however, further trials are needed, especially in non-Western countries. Aims To test the effects of brief CBT for Chinese patients with schizophrenia in the community (trial registration: ChiCTR-TRC-13003709). Method A total of 220 patients with schizophrenia from four districts of Beijing were randomly assigned to either brief CBT plus treatment as usual (TAU) or TAU alone. Patients were assessed at baseline, post-treatment and at 6- and 12-month follow-ups by raters masked to group allocation...
March 2017: British Journal of Psychiatry
https://read.qxmd.com/read/28033512/the-beliefs-about-paranoia-scale-confirmatory-factor-analysis-and-tests-of-a-metacognitive-model-of-paranoia-in-a-clinical-sample
#30
JOURNAL ARTICLE
Elizabeth K Murphy, Sarah Tully, Melissa Pyle, Andrew I Gumley, David Kingdon, Matthias Schwannauer, Douglas Turkington, Anthony P Morrison
This study aimed to confirm the factor structure of the Beliefs about Paranoia Scale (BaPS), a self-report measure to assess metacognitive beliefs about paranoia, and to test hypotheses of a metacognitive model. We hypothesised that positive and negative beliefs about paranoia would be associated with severity of suspiciousness, and that the co-occurrence of positive and negative beliefs would be associated with increased suspiciousness. A total of 335 patients meeting criteria for a schizophrenia spectrum disorder completed the BaPS, the Positive and Negative Syndromes Scale (PANSS), and the Psychotic Symptom Rating Scales (PSYRATS)...
February 2017: Psychiatry Research
https://read.qxmd.com/read/28003288/protocol-for-a-multicentre-study-to-assess-feasibility-acceptability-effectiveness-and-direct-costs-of-triumph-treatment-and-recovery-in-psychosis-integrated-care-pathway-for-psychosis
#31
MULTICENTER STUDY
Shanaya Rathod, Christie Garner, Alison Griffiths, Borislav D Dimitrov, Katherine Newman-Taylor, Chris Woodfine, Lars Hansen, Paul Tabraham, Karen Ward, Carolyn Asher, Peter Phiri, Farooq Naeem, Pippa North, Tariq Munshi, David Kingdon
INTRODUCTION: Duration of untreated psychosis (time between the onset of symptoms and start of treatment) is considered the strongest predictor of symptom severity and outcome. Integrated care pathways that prescribe timeframes around access and interventions can potentially improve quality of care. METHODS AND ANALYSIS: A multicentre mixed methods study to assess feasibility, acceptability, effectiveness and analysis of direct costs of an integrated care pathway for psychosis...
December 21, 2016: BMJ Open
https://read.qxmd.com/read/27902745/utility-of-the-health-of-the-nation-outcome-scales-honos-in-predicting-mental-health-service-costs-for-patients-with-common-mental-health-problems-historical-cohort-study
#32
JOURNAL ARTICLE
Conal Twomey, A Matthew Prina, David S Baldwin, Jayati Das-Munshi, David Kingdon, Leonardo Koeser, Martin J Prince, Robert Stewart, Alex D Tulloch, Alarcos Cieza
BACKGROUND: Few countries have made much progress in implementing transparent and efficient systems for the allocation of mental health care resources. In England there are ongoing efforts by the National Health Service (NHS) to develop mental health 'payment by results' (PbR). The system depends on the ability of patient 'clusters' derived from the Health of the Nation Outcome Scales (HoNOS) to predict costs. We therefore investigated the associations of individual HoNOS items and the Total HoNOS score at baseline with mental health service costs at one year follow-up...
2016: PloS One
https://read.qxmd.com/read/27790373/techcare-mobile-assessment-and-therapy-for-psychosis-an-intervention-for-clients-in-the-early-intervention-service-a-feasibility-study-protocol
#33
JOURNAL ARTICLE
Nusrat Husain, Nadeem Gire, James Kelly, Joy Duxbury, Mick McKeown, Miv Riley, Christopher Dj Taylor, Peter J Taylor, Richard Emsley, Saeed Farooq, Neil Caton, Farooq Naeem, David Kingdon, Imran Chaudhry
OBJECTIVES: Technological advances in healthcare have shown promise when delivering interventions for mental health problems such as psychosis. The aim of this project is to develop a mobile phone intervention for people with psychosis and to conduct a feasibility study of the TechCare App. METHODS: The TechCare App will assess participant's symptoms and respond with a personalised guided self-help-based psychological intervention with the aim of exploring feasibility and acceptability...
2016: SAGE Open Medicine
https://read.qxmd.com/read/27746054/measuring-common-responses-to-psychosis-assessing-the-psychometric-properties-of-a-new-measure
#34
MULTICENTER STUDY
Sarah Tully, Adrian Wells, Melissa Pyle, Jemma Hudson, Andrew Gumley, David Kingdon, Matthias Schwannauer, Douglas Turkington, Anthony P Morrison
Responses to psychotic experiences are central to cognitive models of psychosis. The current study aimed to develop and validate a self-report measure of common responses to the experience of psychosis. This measure is needed as cognitive and behavioural responses are implicated in the maintenance of psychosis, but there is currently no measure that comprehensively assesses these maintaining factors. The Measure of Common Responses to psychosis (MCR) was developed and utilised in a sample of 487 participants who met criteria for treatment-resistant schizophrenia...
March 2017: Schizophrenia Research
https://read.qxmd.com/read/27692269/data-science-for-mental-health-a-uk-perspective-on-a-global-challenge
#35
REVIEW
Andrew M McIntosh, Robert Stewart, Ann John, Daniel J Smith, Katrina Davis, Cathie Sudlow, Aiden Corvin, Kristin K Nicodemus, David Kingdon, Lamiece Hassan, Matthew Hotopf, Stephen M Lawrie, Tom C Russ, John R Geddes, Miranda Wolpert, Eva Wölbert, David J Porteous
Data science uses computer science and statistics to extract new knowledge from high-dimensional datasets (ie, those with many different variables and data types). Mental health research, diagnosis, and treatment could benefit from data science that uses cohort studies, genomics, and routine health-care and administrative data. The UK is well placed to trial these approaches through robust NHS-linked data science projects, such as the UK Biobank, Generation Scotland, and the Clinical Record Interactive Search (CRIS) programme...
October 2016: Lancet Psychiatry
https://read.qxmd.com/read/27496180/design-and-protocol-for-the-focusing-on-clozapine-unresponsive-symptoms-focus-trial-a-randomised-controlled-trial
#36
RANDOMIZED CONTROLLED TRIAL
Melissa Pyle, John Norrie, Matthias Schwannauer, David Kingdon, Andrew Gumley, Douglas Turkington, Rory Byrne, Suzy Syrett, Graeme MacLennan, Robert Dudley, Hamish J McLeod, Helen Griffiths, Samantha Bowe, Thomas R E Barnes, Paul French, Paul Hutton, Linda Davies, Anthony P Morrison
BACKGROUND: For around a third of people with a diagnosis of schizophrenia, the condition proves to respond poorly to treatment with many typical and atypical antipsychotics. This is commonly referred to as treatment-resistant schizophrenia. Clozapine is the only antipsychotic with convincing efficacy for people whose symptoms are considered treatment-resistant to antipsychotic medication. However, 30-40 % of such conditions will have an insufficient response to the drug. Cognitive behavioural therapy has been shown to be an effective treatment for schizophrenia when delivered in combination with antipsychotic medication, with several meta-analyses showing robust support for this approach...
August 5, 2016: BMC Psychiatry
https://read.qxmd.com/read/27445354/training-to-enhance-psychiatrist-communication-with-patients-with-psychosis-tempo-cluster-randomised-controlled-trial
#37
RANDOMIZED CONTROLLED TRIAL
Rose McCabe, Paula John, Jemima Dooley, Patrick Healey, Annie Cushing, David Kingdon, Stephen Bremner, Stefan Priebe
BACKGROUND: A better therapeutic relationship predicts better outcomes. However, there is no trial-based evidence on how to improve therapeutic relationships in psychosis. AIMS: To test the effectiveness of communication training for psychiatrists on improving shared understanding and the therapeutic relationship (trial registration: ISRCTN94846422). METHOD: In a cluster randomised controlled trial in the UK, 21 psychiatrists were randomised...
December 2016: British Journal of Psychiatry
https://read.qxmd.com/read/27146475/group-mindfulness-based-intervention-for-distressing-voices-a-pragmatic-randomised-controlled-trial
#38
MULTICENTER STUDY
Paul Chadwick, Clara Strauss, Anna-Marie Jones, David Kingdon, Lyn Ellett, Laura Dannahy, Mark Hayward
Group Person-Based Cognitive Therapy (PBCT) integrates cognitive therapy and mindfulness to target distinct sources of distress in psychosis. The present study presents data from the first randomised controlled trial investigating group PBCT in people distressed by hearing voices. One-hundred and eight participants were randomised to receive either group PBCT and Treatment As Usual (TAU) or TAU only. While there was no significant effect on the primary outcome, a measure of general psychological distress, results showed significant between-group post-intervention benefits in voice-related distress, perceived controllability of voices and recovery...
August 2016: Schizophrenia Research
https://read.qxmd.com/read/26996274/worry-processes-in-patients-with-persecutory-delusions
#39
JOURNAL ARTICLE
Helen Startup, Katherine Pugh, Graham Dunn, Jacinta Cordwell, Helen Mander, Emma Černis, Gail Wingham, Katherine Shirvell, David Kingdon, Daniel Freeman
OBJECTIVES: Worry may be common in patients with paranoia and a contributory causal factor in the occurrence of the delusions. A number of psychological mechanisms have been linked to the occurrence of worry in emotional disorders but these are yet to be investigated in psychosis. The primary aim of the study was to test the links between five main worry mechanisms - perseverative thinking, catastrophizing, stop rules, metacognitive beliefs, and intolerance of uncertainty - and the cognitive style of worry in patients with persecutory delusions...
November 2016: British Journal of Clinical Psychology
https://read.qxmd.com/read/26971071/cognitive-behavior-therapy-for-psychosis-based-guided-self-help-cbtp-gsh-delivered-by-frontline-mental-health-professionals-results-of-a-feasibility-study
#40
RANDOMIZED CONTROLLED TRIAL
Farooq Naeem, Rupy Johal, Claire McKenna, Shanaya Rathod, Muhammad Ayub, Tania Lecomte, Nusrat Husain, David Kingdon, Saeed Farooq
Availability of Cognitive Behavior Therapy for psychosis (CBTp) is limited in spite of strong evidence base. The purpose of this study was to determine the feasibility of a CBTp based Guided Self-help (CBTp-GSH) in comparison to Treatment As Usual (TAU). The secondary outcomes were a reduction of symptoms of schizophrenia using Positive and Negative Symptom Scale (PANSS) & Disability (WHO DAS 2.0). A total of 33 adults with a DSM-IV diagnosis of schizophrenia was recruited from community mental health services in Kingston, ON, Canada, and randomly assigned to the 12-16week intervention with TAU (Treatment), or TAU alone (Control)...
May 2016: Schizophrenia Research
keyword
keyword
69606
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.